BristolMyers raises forecasts on strong sales of stroke and cancer drugs
Bristol-Myers raises forecasts on strong sales of stroke and cancer drugs
The US pharmaceutical company beat expectations on earnings and revenue in the first quarter
More From BioPortfolio on "Bristol-Myers raises forecasts on strong sales of stroke and cancer drugs"